GLP-1 receptor agonist medications have gained significant attention in recent years. Originally developed to help individuals with type 2 diabetes control their blood sugar, these drugs have since shown additional benefits.
Researchers later found that they could also promote weight loss by curbing appetite and prolonging feelings of fullness. Today, medications like Ozempic, Wegovy, and similar options are used by millions worldwide.
Early studies mainly examined their impact on blood glucose, body weight, and heart health. But scientists have begun noticing that these drugs may also influence brain functions.
Some research indicates that users of GLP-1 medications tend to report reduced cravings for alcohol and other addictive substances. Others show improved self-control, making it easier to resist certain impulses and temptations.
Such observations have led researchers to ask an intriguing question: Could drugs initially designed for diabetes and weight management also impact behaviors linked to criminal activity and violence?
A recent study published in *Criminology* explores this possibility further. Led by Dr. Daniel C. Semenza at Rutgers University, the research aimed to see if GLP-1 medications might influence how certain risk factors relate to violent behaviors.
The study analyzed data from a nationally representative U.S. survey conducted in 2025, including 821 adults who had used GLP-1 medications at some point. The team focused on two factors traditionally associated with violence: impulsivity and alcohol consumption.
Impulsivity refers to acting without thoroughly considering consequences. People prone to impulsive behavior often react swiftly when upset or stressed, struggling to control their emotions or delay responses.
Alcohol consumption can also elevate violent tendencies by impairing judgment, reducing self-control, and making individuals more prone to aggressive actions they might not otherwise consider.
The study confirmed that both impulsivity and alcohol use correlate with increased violent crime. Interestingly, differences emerged when comparing current users of GLP-1 medications with those who had previously taken them.
Among current users, the link between these risk factors and violent behavior was notably weaker.
Put simply, people actively taking GLP-1 drugs still drank alcohol or acted impulsively, but these behaviors were less likely to escalate into violent crimes compared to those who had discontinued use.
The most pronounced difference appeared with impulsivity. The results related to alcohol use were less definitive but still hinted at potential benefits.
Scientists are not entirely sure why this occurs yet. One theory suggests that GLP-1 medications might influence brain areas involved in reward, stress regulation, and decision-making. These regions are vital for controlling urges, emotions, and assessing consequences.
It’s believed that these drugs may modify some of these neural systems, helping certain individuals better regulate their behaviors.
These findings align with other recent research hinting that GLP-1 drugs might have unexpected effects beyond controlling weight and blood sugar. Growing interest surrounds their potential role in reducing addictive behaviors, such as heavy drinking and substance abuse.
This new research extends that curiosity, suggesting these medications could also impact behaviors related to aggression and violence.
However, the researchers emphasize that these findings do not prove that GLP-1 drugs prevent crime or violent acts. Violent behavior is highly complex, influenced by mental health, childhood experiences, relationships, socioeconomic factors, alcohol consumption, and more. Medication alone is unlikely to eliminate these risks.
Because the study relies on survey data, it cannot establish direct cause-and-effect relationships. There might be differences between current and former users that weren’t fully captured.
Further research is essential to determine whether the medications truly influence behavior and to uncover the biological mechanisms behind these effects.
Overall, these findings highlight how medications designed for one health issue can sometimes have unexpected influences on other aspects of mental and behavioral health.
The strong association with impulsivity is particularly noteworthy since poor impulse control links to many adverse outcomes, including addiction, risky behaviors, and interpersonal violence.
Although more research is needed, the evidence suggests that GLP-1 medications might affect brain functions in ways that scientists are only beginning to understand. As their usage increases globally, studying their broader impacts on human behavior may become an important area of public health research.
If you’re interested in diabetes management, consider reading about how bananas and honey might help regulate blood sugar.
For additional health insights, check out recent studies on vitamin D, which may help prevent serious diabetes complications, and plant-based proteins that could potentially reverse type 2 diabetes.
Source: Rutgers University.